Low Molecular Weight Opioid Peptide Esters Could be Developed as a New Class of Analgesics.

Loading...
Thumbnail Image

Date

2011

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

202
views
247
downloads

Citation Stats

Abstract

Low molecular weight opioid peptide esters (OPE) could become a class of analgesics with different side effect profiles than current opiates. OPE may have sufficient plasma stability to cross the blood brain barrier (BBB), undergo ester hydrolysis and produce analgesia. OPE of dipeptides, tyr-pro and tyr-gly conjugated to ethanol have a structure similar to the anesthestic agent, etomidate. Based upon the analgesic activity of dipeptide opioids, Lipinski's criteria, and permeability of select GABA esters to cross the BBB, opioid peptides (OP) conjugated to ethanol, cholesterol or 3-glucose are lead recommendations. Preliminary animal data suggests that tyr-pro-ethyl ester crosses the BBB and unexpectedly produces hyperalgesia. Currently, there are no approved OP analgesics available for clinical use. Clinical trials of good manufacturing practice OP administered to patients suffering from chronic pain with indwelling intrathecal pumps could resolve the issue that OP may be superior to opiates and may redirect research.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.4137/PMC.S6803

Publication Info

Goldberg, Joel S (2011). Low Molecular Weight Opioid Peptide Esters Could be Developed as a New Class of Analgesics. Perspect Medicin Chem, 5. pp. 19–26. 10.4137/PMC.S6803 Retrieved from https://hdl.handle.net/10161/10355.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.